2022
DOI: 10.1590/0102-311xpt041722
|View full text |Cite
|
Sign up to set email alerts
|

Avaliação das ações de controle do câncer de colo do útero no Brasil e regiões a partir dos dados registrados no Sistema Único de Saúde

Abstract: Este estudo teve como objetivo analisar a realização de exames de rastreamento e diagnóstico para o câncer de colo do útero entre mulheres de 25 e 64 anos, bem como o atraso para o início do tratamento no Brasil e suas regiões geográficas no período de 2013 a 2020. As informações sobre os procedimentos e as estimativas populacionais foram obtidas nos sistemas de informações do Sistema Único de Saúde (SUS) e da Agência Nacional de Saúde Suplementar (ANS). Foram calculados indicadores de cobertura do exame de Pa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
5
0
6

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 11 publications
(11 citation statements)
references
References 30 publications
0
5
0
6
Order By: Relevance
“…In other studies with the target population of women aged 25 to 64 years, Pap smear coverage in Brazil was lower than recommended, and the number of women diagnosed among those screened was lower than the estimated values [11]. According to the World Health Organization, the elimination of cervical cancer by the year 2030 has the goal of 90% of girls up to 15 years of age being vaccinated against HPV, 70% of women between 35 and 45 years of age being screened with a high-performance test, and 90% of those identified with cervical diseases being treated [12].…”
Section: Discussionmentioning
confidence: 60%
“…In other studies with the target population of women aged 25 to 64 years, Pap smear coverage in Brazil was lower than recommended, and the number of women diagnosed among those screened was lower than the estimated values [11]. According to the World Health Organization, the elimination of cervical cancer by the year 2030 has the goal of 90% of girls up to 15 years of age being vaccinated against HPV, 70% of women between 35 and 45 years of age being screened with a high-performance test, and 90% of those identified with cervical diseases being treated [12].…”
Section: Discussionmentioning
confidence: 60%
“…Nevertheless, the 43% found as a total mean of not performing CC in the period is at least double the rate observed in other studies 28 , 29 . This is a result of the difference in the age group and the worsening screening for this disease, which began in 2013 and reached its peak in 2020 26 , 30 .…”
Section: Discussionmentioning
confidence: 99%
“…In reference to this reality, although screening and detection tests are available for this malignancy, in the last decade there was a significant decline in the coverage of preventive tests, such as cytopathological and histopathological tests, in regions of Brazil, especially in the North, Southeast and South, in addition to an increase in the time it takes to start treatment [35,36]. Additionally, the North Region has one of the highest rates of cervical cancer in Brazil but does not have the same prevalence of confirmed cases of HPV [37].…”
Section: Discussionmentioning
confidence: 99%